Document is current

Any future updates will be listed below

Evaluation of the Efficacy and Safety of Adding Pregabalin to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Double-blind Placebo-controlled Clinical Trial

Crossref DOI link: https://doi.org/10.32598/ijpcp.27.3.2167.3

Published Online: 2022-01-01

Update policy: https://doi.org/10.32598/nsp.crossmark-policy

About CrossMark